Carrol Gamble

Director of the Liverpool Clinical Trials Centre, Prof of medical statistics at the University of Liverpool, interested in trials methodology research

[Carrol Gamble @Carrol_Gamble]

@prw_paula @OBrienK57 @LivUniHDS @livuninews @LivUniIPH @livuni_LCTC @Bally_Tracy @KevinJMunro @UKCTUNetwork

[Carrol Gamble @Carrol_Gamble]

After 18 years from first discussion to publication https://t.co/ZyK5c1NUbO it’s time to celebrate the TOPs trial at the top. Thanks to everyone who helped along the way

[Carrol Gamble @Carrol_Gamble]

After 18 years from first discussion to publication https://t.co/ZyK5c1NUbO it’s time to celebrate the TOPs trial at the top. Thanks to everyone who helped along the way

[Marion Campbell @MarionKCampbell]

It doesn’t matter how innovative or efficient your trial design is, unless your trial is managed well, it will likely not succeed as planned. Having high quality #TrialManagement is a fundamental requirement 1/8
#MethodologyMonday

[Dr Louise Newson @drlouisenewson]

Tune into @thismorning today, where I will answer your questions on the #perimenopause and #menopause. Explore our resources on the free @balanceMeno website and app #thismorning

[COPE @CopeTrial]

Fantastic to get the opportunity to share the @CopeTrial embedded study findings at #ICTMC2022 Go @kerry_woolfall 👏 Thank you to our amazing #NHS & the women involved for your work helping to answer such important questions 🤰 @BethDeja @adweeks @livuni_LCTC @ResearchSanyu

[Carrol Gamble @Carrol_Gamble]

Fantastic team night out @livuni_LCTC #ICTMC2022

[Prof Amanda Farrin 🕷️🇪🇺 💙 @amanda_horler]

Fascinating keynote from @IsabelleBoutron at #ICTMC2022 , ending with the message that we can always do more to ensure better trials

[COMET @COMETinitiative]

Trial funders take note! Be more like ⁦@hrbtmrn⁩ and ask applicants whether they have searched the COMET database to check whether a COS exits #ICTMC2022

[HRB-TMRN @hrbtmrn]

📸 And then there was.... many!! @ictmc2022 Proud of how much our network has grown, & eager to work with our colleagues & friends across @hrbireland infrastructures on #trialsmethodology (we also have a bit of fun along the way!)

[Paul Mouncey @PaulMouncey]

Great to hear from @TimoTolppa about the important work on the applicability of PRECIS-2 in LMICs. Sounds like an exciting programme of research ahead.

#ICTMC22

[UKTMN @UKTMN]

We had a great time at the #UKTMN networking event at #ICTMC2022 yesterday! Finally some face-face discussion with our lovely members! Really helpful to discuss our #professionaldevelopment work and get feedback directly from TMs!
#UKTMN2022

[Paula Williamson FMedSci @prw_paula]

Good turnout at #ictmc2022 for Jess Griffiths’ talk about estimating the carbon footprint of a clinical trial ⁦@MRCNIHRTMRP⁩ ⁦@mattsydes⁩ ⁦@kerryhood⁩ @carrol_gamble ⁦@livuni_LCTC⁩ ⁦@GilliesKatie⁩

[MRC-NIHR Trials Methodology Research Partnership @MRCNIHRTMRP]

The next TMRP webinar hosted by @UKTMN:
GCP but not as you know it… Development of Good Statistical Practice Training
Wednesday 9 June 2021 – 1-2pm
Presented by Prof Deb Stocken (University of Leeds)

For more info and registration: https://t.co/LjCfFLpish

[Carrol Gamble @Carrol_Gamble]

@kerryhood @GilliesKatie @hsru_aberdeen @aberdeenuni Now that sounds like a plan!!

[Carrol Gamble @Carrol_Gamble]

@GilliesKatie @kerryhood @hsru_aberdeen @aberdeenuni Excellent news! Are you sure you can’t be persuaded about the Bolli?

[HRB-TMRN @hrbtmrn]

Calling all #Funders - Do you fund #ClinicalTrials that include collection of #QualitiativeData? @QUESTScentre would welcome your views sharing this type of data. Please contact [email protected] to take part & share your views. #TrialsMethodology

[Tony Marson FMedSci @TonyMarson2]

And more from our amazing network. Levetiracetam not clinically or cost effective first line in generalised epilepsy. @sanad2trial @ILAEBRITISH
@theABN_Info
@BPNA_org @epilepsyaction @epilepsy_liv
@livuni_LCTC @CHEMEBangor
https://t.co/qHd4ymUv1p

[Tony Marson FMedSci @TonyMarson2]

Fantastic achievement from our UK network. Lamotrigine clinically & cost effective first line in focal epilepsy, levetiracetam and zonisamide are not. @sanad2trial @ILAEBRITISH
@theABN_Info
@BPNA_org @epilepsyaction @epilepsy_liv
@livuni_LCTC @CHEMEBangor

https://t.co/r8mb27gfhK

[HEAL-COVID @HEAL_COVID]

We have now received all the regulatory approvals we need for @HEAL_COVID & will be sending out document packs to the >60 hospitals who have so far expressed an interest in joining our study in the next 48h.
Don’t miss out, get in touch (info in bio) & join us! #AvoidFOMO